Special Issue "Cell-Based Therapy of Cardiovascular Diseases"
Deadline for manuscript submissions: closed (1 December 2022) | Viewed by 8882
Interests: heart disease; cardiovascular; diabetes; molecular and cellular therapeutics; stem cells
Special Issues, Collections and Topics in MDPI journals
Despite advances in medicine, cardiovascular diseases (CVDs) are still the leading cause of death worldwide. According to WHO key facts, about 17.9 million people died from CVDs in 2019, representing 32% of all global deaths (https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)#:~:text=Key%20facts,to%20heart%20attack%20and%20stroke). The development of stem cell biology has enabled cell-based therapy as a promising approach to promote the repair of injured tissue and replenish new and functional cells.
In this Special Issue, we invite cardiologists and cell and developmental biologists to submit research on the strategies to boost and improve our understanding of the mechanism of cell-based therapy for the treatment of cardiovascular diseases. Topics include but are not limited to pluripotent stem cells, multipotent stem cells, and progenitor cells and their derivatives, including nanovesicles and exosomes, novel cellular delivery approaches and monitoring modality, preclinical studies, etc. We hope this Special Issue will provide new insights into understanding the key factors promoting cell-based therapy efficacy, attesting new cellular or molecular interventions, and promoting novel cellular therapeutic strategies for the treatment of cardiovascular diseases.
Dr. Lei Ye
Prof. Dr. Feng Cao
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- heart diseases
- stem cell biology
- cell transfer therapy
- tissue engineering
- cell derivatives